期刊文献+

水飞蓟宾-磷脂复合物的药代动力学和药效学研究进展 被引量:10

Recent Development in Pharmacokinetics and Pharmacodynamics of Silybin-phosphatidylcholine Complex
暂未订购
导出
摘要 结合一系列体外实验、动物实验、人体实验及临床试验,综述水飞蓟宾-磷脂复合物的药代动力学、药效学及其安全性与耐受性的研究进展。大量的研究表明,与普通水飞蓟宾制剂相比,水飞蓟宾-磷脂复合物脂溶性增大,更容易透过细胞膜,吸收加快,生物利用度提高,活性增强,极具临床应用和研究价值。 Recent development in the pharmacokinetics, pharmacodynamics, safety and tolerability of silybin-phosphatidylcholine complex was reviewed, by way of varied in vitro tests, animal and human experiments and clinical trials. Lots of related researches have shown that compared with common silybin preparations, silybin-phosphatidylcholine complex is more liposoluble, permeable through cell membrance and absorbable and has good bioavailability, resulting in increased activity, which has great value of clinical use and reseach.
作者 赵暖 栾立标
出处 《药学进展》 CAS 2006年第7期295-299,共5页 Progress in Pharmaceutical Sciences
关键词 水飞蓟宾 水飞蓟宾-磷脂复合物 脂溶性 生物利用度 药代动力学 药效学 Silybin Silybin-phosphatidylcholine complex Liposoluble Bioavailability Phannacokinetics Pharmacodynamics
  • 相关文献

参考文献26

  • 1Bombardelli E. Phytosome: new cosmetic delivery sysrtem[J]. Boll Chim Farm, 1991, 130(11): 431-435.
  • 2翟光喜,娄红祥,邹立家,毕殿洲.药物磷脂复合物的研究进展[J].中国药学杂志,2001,36(12):800-803. 被引量:59
  • 3Hikino H, Kiso Y, Wagner H, et al. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits[J]. Planta Med, 1984, 50(3) :248-250.
  • 4Malandrino S, Pifferi G. IdB-1016[J]. Drugs Fur, 1990,15(3):226-227.
  • 5许建文,张光军,陈正跃.水飞蓟宾-卵磷脂复合物制备工艺比较[J].中国生化药物杂志,2002,23(5):245-246. 被引量:14
  • 6Morazzoni P, Montalbetti A, Malandrino S, et al. Comparative pharmacokinetics of silipide and silymarin in rats[J]. Eur J Drug Metab Pharmacokinet , 1993,18(3) :289-297.
  • 7杜海燕.水飞蓟宾—磷脂复合物对高脂肪饮食家兔的保肝作用[J].国外医学:中医中药分册,1998,20(1):44-46.
  • 8Barzaghi N, Crema F, Gatti G, et al. Pharmaeokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex,in healthy human subjects [ J]. Eur J Drug Metab Pharmacokinet, 1990,15(4) :333-338.
  • 9Gatti G, Peruua E, Plasma concentrations of free and conjugated silybin after oral intake of silybinphosphatidylcholine complex in healthy volunteers[J]. Int J Clin Pharmacol Ther , 1994,32(11) :614-619.
  • 10Schandalik R, Gatti G, Perueca E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients [ J ]. Arzneimittelforschung, 1992,42(7) :964-968.

二级参考文献43

  • 1王红喜.微乳制剂的研究进展[J].国外医学(药学分册),1996,23(4):206-211. 被引量:27
  • 2张振涛,王立新,冷江涌,吴宁远.不同结构形态的脂质体磷脂稳定性研究[J].内蒙古医学院学报,1996,18(1):30-31. 被引量:2
  • 3刘方,李三鸣,苏德森.药物-磷脂络合物的研究进展[J].国外医药(合成药.生化药.制剂分册),1996,17(5):300-303. 被引量:11
  • 4江永南 陈济民 等.淫羊藿黄酮磷脂复合物的制备及其剂型研究.2000中国药学会学术年会论文集[M].宁波:中国药学会,2000.798.
  • 5Bhattachar SN, Rytting JH, hoh T, et al. The effects of complexation with hydrogenated phospholipid on the transport of salicylic acid, diclofenac and indomethacin across snake stratum cornetun [ J ]. Int J Pharm, 1992,79 : 263-271.
  • 6Wu FJ, Flach CR, Seaton BA, et al. Stability of annexin V in ternary complexes with Ca2 + and anionic phospholipids: IR studies of monolayer and buik phases[J]. Biochem, 1999,38(2) :792-799.
  • 7Lundberg B. Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures[ J]. J Pharm Sci, 1994,83 ( 1 ) : 72-75.
  • 8Rahman A, Husain SR, Siddiqui J, et al. liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells[J]. J Natl cancer inst, 1992,84:1909-1915.
  • 9Gasco MR, Pattarino F, Lattanzl F. Long-acting delivery systems for peptides: reduced plasma testosteone levels in male rats after a single injection[J]. Int J Pharm, 1990,62(2,3) : 119-123.
  • 10Lee M J, Lee MH, Shim CK. Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338[J]. Int J Pharm,1995,113(2) :175-187.

共引文献91

同被引文献110

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部